VistaGen Therapeutics


VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need.


Org chart

Shawn K. Singh
CEO & Director
Collapse
Reid Adler
Chief Legal Officer
Trisha Fitzmaurice
SVP, Human Resources
Joshua Prince
VP, Strategic Insights & Analytics
Mark J. Ginski
SVP, Head of CMC
Michelle Peters Wellington
VP, Communications
Ross A. Baker
VP, Global Medical Affairs
Edith Perez
Senior Executive Assistant
Mark A. McPartland
VP, Corporate Development
Mark Flather
VP, Investor Relations

Board & advisors



Offices